Tissue Regenix Group (LSE:TRX) EPS (Basic) : £-0.02 (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group EPS (Basic)?

Tissue Regenix Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was £-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.02.

Tissue Regenix Group's EPS (Diluted) for the six months ended in Dec. 2023 was £-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.02.

Tissue Regenix Group's EPS without NRI for the six months ended in Dec. 2023 was £-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 41.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 54.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 33.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Tissue Regenix Group's highest 3-Year average EPS without NRI Growth Rate was 62.70% per year. The lowest was -37.20% per year. And the median was 17.30% per year.

Tissue Regenix Group EPS (Basic) Historical Data

The historical data trend for Tissue Regenix Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group EPS (Basic) Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.60

-0.21

-0.05

-0.03

-0.02

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-0.02	-0.01	-0.01	-0.01

Tissue Regenix Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tissue Regenix Group's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.353	-	0)	/	70.427
	=	-0.02

Tissue Regenix Group's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.648	-	0)	/	70.496
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.02

Tissue Regenix Group (LSE:TRX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Tissue Regenix Group EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.